DynamX - Drug Eluting Coronary Bioadaptor System
The DynamX Drug Eluting Coronary Bioadaptor System is a significant innovation in the treatment of coronary artery disease. Going beyond drug-eluting stents (DES), DynamX represents one of the most significant breakthroughs in implant design in the past 30 years.
Product Details
DynamX is the first coronary artery implant designed to adapt to vessel physiology. The device’s ability to accommodate the artery’s dynamic, natural movement has been shown to:
- Maintain the ability for positive adaptive remodeling
- Restore vessel function
- Allow for return towards baseline angulation
The loss of vessel movement, which occurs with DES, has been associated with major adverse cardiac events (MACE).13 By adapting to the vessel, DynamX offers the potential to reduce the incidence of MACE.
How DynamX Works
DynamX is a cobalt chromium implant coated in a proven bioresorbable polymer and a low-dose anti-proliferative drug. Deployed similar to a DES, it initially supports the coronary artery during vessel healing, demonstrating excellent radial strength.
Over six months, the polymer resorbs, freeing unique “uncaging elements” which allow DynamX to move along with the natural expansion and contraction of the vessel.
These uncaging elements are located at low stress regions of the device’s sinusoidal rings that can move safely and independently within the frame of the bioadaptor. Once uncaged, DynamX allows the vessel to move naturally and respond to patients’ physiologic requirements in ways that traditional DES has been unable to deliver for millions of patients.
Customer reviews
No reviews were found for DynamX - Drug Eluting Coronary Bioadaptor System. Be the first to review!